A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment

NCT07324616 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment (HI)

Interventions

DRUG: EDG-7500

Sponsor

Edgewise Therapeutics, Inc.